propiolactone has been researched along with Pneumonia, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basler, CF; Jureka, AS; Silvas, JA | 1 |
| Chen, W; Du, J; Duan, K; Gao, X; Guo, J; Guo, W; Huang, L; Huang, S; Li, X; Lu, J; Meng, Z; Pan, A; Peng, C; Shen, S; Shi, Z; Wan, X; Wang, Q; Wang, W; Wang, X; Wang, Y; Wang, Z; Wu, C; Xia, S; Xie, Z; Yang, X; Yang, Y; You, W; Yuan, Z; Zhang, H; Zhang, L; Zhang, W; Zhang, Y; Zhao, D; Zhou, W | 1 |
1 trial(s) available for propiolactone and Pneumonia, Viral
| Article | Year |
|---|---|
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aluminum Hydroxide; Antibodies, Neutralizing; Antibodies, Viral; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Dose-Response Relationship, Immunologic; Double-Blind Method; Female; Humans; Immunogenicity, Vaccine; Injections, Intramuscular; Male; Pandemics; Pneumonia, Viral; Propiolactone; SARS-CoV-2; Vaccines, Inactivated; Viral Vaccines; Young Adult | 2020 |
1 other study(ies) available for propiolactone and Pneumonia, Viral
| Article | Year |
|---|---|
Propagation, Inactivation, and Safety Testing of SARS-CoV-2.
Topics: Animals; Betacoronavirus; Cellulose; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Culture Media; Formaldehyde; Guanidines; HEK293 Cells; Humans; Pandemics; Phenols; Pneumonia, Viral; Propiolactone; SARS-CoV-2; Sepharose; Vero Cells; Viral Plaque Assay; Virus Inactivation | 2020 |